Key facts
- This page summarizes Jeffrey Z. Mann's Form 4 filing for Embecta Corp. (EMBC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Aug 2026, 10:47.
Jeffrey Z. Mann - 12 Aug 2026 Form 4 Insider Report for Embecta Corp. (EMBC)
- Reporting relationship
- Pres, Pharm Svc&Prod Mgmt, CLO
- Issuer ticker
- EMBC
- Reported as of
- 12 Aug 2026
- Net transaction value
- +$99,800
- SEC form
- 4
- Accepted by SEC
- 13 Aug 2026, 10:47:14 UTC
- Prior SEC filing
- 03 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey Z. Mann
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey Z. Mann filed Form 4 for Embecta Corp. (EMBC) on 13 Aug 2026.
Change
- Previous filing in this sequence was filed on 03 Dec 2025.
- Current net transaction value: +$99,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001784562
Primary reporting owner
Mann Jeffrey Z
- Relationship
- Pres, Pharm Svc&Prod Mgmt, CLO
- Address
- EMBECTA CORP., 300 KIMBALL DRIVE, PARSIPPANY
- Signature
- /s/ Jeffrey Z. Mann
- Signature date
- 13 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EMBC
transaction
Common Stock
Purchase
- Transaction value
- $99,800
- Shares
- +20,000
- Change %
- +8.2%
- Price
- $4.99
- Shares after
- 262,915
- Date
- 12 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.